Chapter 11: Generic Drugs: ANDAs, Section 505(b)(2) NDAs, Patents and Exclusivities

January 1, 2008

Related people

William B. Schultz

Media contact

Diana L. Courson
Chief Marketing Officer
Email | 202.778.1871